Breaking News Instant updates and real-time market news.

MYL

Mylan

$36.53

-0.33 (-0.90%)

11:33
12/01/17
12/01
11:33
12/01/17
11:33

FDA approves Mylan's Ogivri, a biosimilar for trastuzumab

Mylan and Biocon announced that the U.S. Food and Drug Administration has approved Mylan's Ogivri, a biosimilar to Herceptin, co-developed with Biocon. Ogivri has been approved for all indications included in the label of the reference product, Herceptin, including for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer. Ogivri is the first FDA-approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the U.S. Mylan anticipates potentially being the first company to offer a biosimilar to Herceptin, as a result of Mylan's ability to secure global licenses for its trastuzumab product from Genentech and Roche earlier this year. This milestone secured a clear pathway to commercialize Mylan's biosimilar to Herceptin in various markets globally.

  • 03

    Dec

MYL Mylan
$36.53

-0.33 (-0.90%)

11/07/17
SUSQ
11/07/17
NO CHANGE
Target $47
SUSQ
Positive
Mylan positioned to deliver near-term growth, says Susquehanna
Susquehanna analyst Andrew Finkelstein believes Mylan is favorably positioned relative to peers to deliver near-term growth despite headwinds while advancing a long-term strategy. He said the shares warrant a premium to traditional peers who face tougher growth challenges. Finkelstein reiterated his Positive rating and raised his price target to $47 from $43 on Mylan.
11/07/17
RBCM
11/07/17
NO CHANGE
Target $37
RBCM
Sector Perform
Mylan price target raised to $37 from $32 at RBC Capital
RBC Capital analyst Randall Stanicky raised his price target on Mylan to $37 and kept his Sector Perform rating. The analyst says that in spite of two consecutive challenging quarters that showed the company is not immune to broader sector challenges, Mylan's relative positioning remains favorable to peers, adding that generic Copaxone performance is helpful in the near term.
12/01/17
WELS
12/01/17
NO CHANGE
WELS
Wells not seeing Amazon talks as good news for Mylan, others
CNBC last night reported that Amazon.com (AMZN) is in exploratory talks with Mylan (MYL) and Novartis' Sandoz (NVS) regarding a potential entry into the pharmacy space. While the market might consider this good news for Mylan and other generics as a sign of potential preferred supplier agreements, Wells Fargo analyst David Maris says he's more cautious. Amazon entering the pharmacy market could be a negative headwind for retail generics and potentially branded over-the-counter products, Maris argues. He believes Amazon would source at competitive prices and that "increased price transparency may cause traditional retailers to push harder for price concessions."
12/01/17
WELS
12/01/17
NO CHANGE
Target $1525
WELS
Outperform
Amazon price target raised to $1,525 from $1,430 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Amazon.com (AMZN) to $1,525 to reflect increased outer-year estimates for Web Services as well as a higher sum-of-the-parts valuation. The stock closed yesterday up $15.48 to $1,176.75. The analyst highlights the "very successful" five-day Amazon Wed Services conference in Las Vegas, "record-breaking" early holiday sales data, and another healthcare industry development with CNBC reporting the company is in talks with generic manufacturers Mylan (MYL) and Novartis (NVS). Sena sees an increasing likelihood that Amazon "ultimately becomes a disruptor" in healthcare, with generics representing a potential point of entry. The Wells Fargo Healthcare team sees generics as a "simple entry point" in pharma as it involves many players with ready supply and a price competitive market, Sena tells investors in a research note. The analyst keeps an Outperform rating on Amazon.

TODAY'S FREE FLY STORIES

13:45
12/13/17
12/13
13:45
12/13/17
13:45
General news
Breaking General news story  »

FOMC Forecasts to be…

13:45
12/13/17
12/13
13:45
12/13/17
13:45
General news
FOMC Meeting Announcement Federal Funds Rate to be reported at 14:00 »

FOMC Meeting Announcement…

TMUS

T-Mobile

$63.48

0.41 (0.65%)

13:44
12/13/17
12/13
13:44
12/13/17
13:44
Recommendations
T-Mobile analyst commentary  »

T-Mobile acquisition of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TNC

Tennant

$62.85

0.8 (1.29%)

13:43
12/13/17
12/13
13:43
12/13/17
13:43
Hot Stocks
Tennant says will 'carefully evaluate' views of shareholder PrimeStone »

Tennant Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$54.87

-0.34 (-0.62%)

13:40
12/13/17
12/13
13:40
12/13/17
13:40
Options
Notable call buying in Nektar as shares reach 52-week highs »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$11.01

0.135 (1.24%)

13:35
12/13/17
12/13
13:35
12/13/17
13:35
Options
Express put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

DBD

Diebold

$17.78

-0.725 (-3.92%)

13:22
12/13/17
12/13
13:22
12/13/17
13:22
Recommendations
Diebold analyst commentary  »

Diebold needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVG

Convergys

$24.12

0.15 (0.63%)

13:21
12/13/17
12/13
13:21
12/13/17
13:21
Conference/Events
Convergys management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

$NSD

NASDAQ Market Internals

13:17
12/13/17
12/13
13:17
12/13/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
12/13/17
12/13
13:16
12/13/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.48

-0.14 (-0.26%)

, EADSY

Airbus

$25.54

0.22 (0.87%)

13:15
12/13/17
12/13
13:15
12/13/17
13:15
Periodicals
Delta to place 'huge' jet order with Airbus, CNN says »

Delta Air Lines (DAL)…

DAL

Delta Air Lines

$53.48

-0.14 (-0.26%)

EADSY

Airbus

$25.54

0.22 (0.87%)

BA

Boeing

$293.91

3.97 (1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SBCF

Seacoast Banking

$25.52

0.21 (0.83%)

13:15
12/13/17
12/13
13:15
12/13/17
13:15
Conference/Events
Seacoast Banking management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HBI

Hanesbrands

$21.31

0.355 (1.69%)

13:15
12/13/17
12/13
13:15
12/13/17
13:15
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.49

-0.135 (-0.25%)

, BA

Boeing

$293.97

4.0261 (1.39%)

13:11
12/13/17
12/13
13:11
12/13/17
13:11
Periodicals
Delta to order about 100 jets from Airbus, CNN says »

Shares of Boeing (BA) are…

DAL

Delta Air Lines

$53.49

-0.135 (-0.25%)

BA

Boeing

$293.97

4.0261 (1.39%)

EADSY

Airbus

$25.54

0.22 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SAFM

Sanderson Farms

$167.00

1.08 (0.65%)

13:09
12/13/17
12/13
13:09
12/13/17
13:09
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NDSN

Nordson

$124.22

-0.8 (-0.64%)

, PIR

Pier 1 Imports

$5.80

0.34 (6.23%)

13:09
12/13/17
12/13
13:09
12/13/17
13:09
Earnings
Notable companies reporting after market close »

Notable companies…

NDSN

Nordson

$124.22

-0.8 (-0.64%)

PIR

Pier 1 Imports

$5.80

0.34 (6.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AMN

AMN Healthcare

$48.20

-0.1 (-0.21%)

13:09
12/13/17
12/13
13:09
12/13/17
13:09
Conference/Events
AMN Healthcare management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

DECK

Deckers Brands

$78.28

1.15 (1.49%)

13:06
12/13/17
12/13
13:06
12/13/17
13:06
Periodicals
Marcato poised to win in proxy battle with Deckers, Reuters reports »

Marcato Capital appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$81.66

-0.345 (-0.42%)

13:03
12/13/17
12/13
13:03
12/13/17
13:03
Hot Stocks
Medtronic pays $12M in multistate settlement over marketing »

Massachusetts will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$267.00

0.2237 (0.08%)

12:57
12/13/17
12/13
12:57
12/13/17
12:57
Periodicals
Trump says would sign tax bill with 21% corporate rate, CNBC reports 

Reference Link

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$267.00

0.2237 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIZ

Assurant

$99.77

-0.53 (-0.53%)

12:55
12/13/17
12/13
12:55
12/13/17
12:55
Conference/Events
Assurant management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$267.23

0.45 (0.17%)

12:48
12/13/17
12/13
12:48
12/13/17
12:48
Periodicals
Breaking Periodicals news story on S&P 500, SPDR S&P 500 ETF Trust »

Corporate AMT not in tax…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$267.23

0.45 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$61.60

0.39 (0.64%)

12:47
12/13/17
12/13
12:47
12/13/17
12:47
Conference/Events
LHC Group management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TOSYY

Toshiba, also use TOSBF

$16.21

0.035 (0.22%)

, TOSBF

Toshiba, also use TOSYY

$2.69

0.004 (0.15%)

12:47
12/13/17
12/13
12:47
12/13/17
12:47
Upgrade
Toshiba, also use TOSBF, Toshiba, also use TOSYY rating change  »

Toshiba upgraded to Buy…

TOSYY

Toshiba, also use TOSBF

$16.21

0.035 (0.22%)

TOSBF

Toshiba, also use TOSYY

$2.69

0.004 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$21.65

-0.025 (-0.12%)

12:45
12/13/17
12/13
12:45
12/13/17
12:45
Conference/Events
Easterly Government Properties management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.